Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis

BACKGROUND: Several studies have been conducted to explore the association between the use of proton pump inhibitors (PPIs) and hepatic encephalopathy (HE) risk in patients with liver cirrhosis. However, their results are controversial. AIM: To perform a systematic review and meta-analysis to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yun-Jie, Cao, Zong-Xun, Li, Yong, Feng, Shun-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558435/
https://www.ncbi.nlm.nih.gov/pubmed/31210718
http://dx.doi.org/10.3748/wjg.v25.i21.2675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558435/
https://www.ncbi.nlm.nih.gov/pubmed/31210718
http://dx.doi.org/10.3748/wjg.v25.i21.2675

Ejemplares similares